Definition
Neoadjuvant therapy is an auxiliary therapy (e.g., androgen ablation in prostate cancer) administered prior to another therapy (e.g., surgery or radiation). It is given prior to surgery in an attempt to decrease the size of the tumor. It is performed in an attempt to make the tumor easier to remove and to increase the chances that removal of the tumor is curative.
Characteristics
In most solid tumors, surgery remains the initial primary modality of treatment. With the increasing effectiveness of systemic therapies (chemotherapy and hormonal therapy) in advanced disease stages and also in the postoperative “adjuvant” setting, studies were instituted in many solid tumor types using systemic therapies prior to surgery. Advantages of this approach may include:
Downstaging of the tumor allowing for less extensive surgery to be performed
Ability to...
See Also
(2012) Ablation. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 14. doi: 10.1007/978-3-642-16483-5_16
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Vogel, C.L. (2015). Neoadjuvant Therapy. In: Schwab, M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27841-9_4005-2
Download citation
DOI: https://doi.org/10.1007/978-3-642-27841-9_4005-2
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-27841-9
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences